...
search icon
gsk-img

GlaxoSmithKline PLC ADR, Common Stock

GSK

NYQ

$35.06

-$0.04

(-0.11%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$71.53B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
23.245
Volume info-icon
This is the total number of shares traded during the most recent trading day.
6.02M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
4.44%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.33
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$31.72 L
$44.85 H
$35.06

About GlaxoSmithKline PLC ADR, Common Stock

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameGSKSectorS&P500
1-Week Return4.88%3.05%-0.32%
1-Month Return4.19%6.76%2.75%
3-Month Return-8.15%-1.27%3.94%
6-Month Return-12.37%-2.35%11.01%
1-Year Return-10.24%4.47%23.11%
3-Year Return-23.16%11.65%34.36%
5-Year Return-27.02%43.79%85.19%
10-Year Return-23.74%108.21%200.02%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue33.75B34.10B34.11B29.32B30.33B[{"date":"2019-12-31","value":98.94,"profit":true},{"date":"2020-12-31","value":99.96,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.96,"profit":true},{"date":"2023-12-31","value":88.9,"profit":true}]
Cost of Revenue11.86B11.70B11.60B9.55B8.56B[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.66,"profit":true},{"date":"2021-12-31","value":97.81,"profit":true},{"date":"2022-12-31","value":80.54,"profit":true},{"date":"2023-12-31","value":72.2,"profit":true}]
Gross Profit21.89B22.39B22.51B19.77B21.76B[{"date":"2019-12-31","value":97.25,"profit":true},{"date":"2020-12-31","value":99.48,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":87.82,"profit":true},{"date":"2023-12-31","value":96.68,"profit":true}]
Gross Margin64.85%65.68%65.99%67.42%71.76%[{"date":"2019-12-31","value":90.38,"profit":true},{"date":"2020-12-31","value":91.52,"profit":true},{"date":"2021-12-31","value":91.96,"profit":true},{"date":"2022-12-31","value":93.95,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses14.93B14.61B16.31B13.34B15.02B[{"date":"2019-12-31","value":91.54,"profit":true},{"date":"2020-12-31","value":89.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.77,"profit":true},{"date":"2023-12-31","value":92.08,"profit":true}]
Operating Income6.96B7.78B6.20B6.43B6.75B[{"date":"2019-12-31","value":89.44,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":79.67,"profit":true},{"date":"2022-12-31","value":82.65,"profit":true},{"date":"2023-12-31","value":86.66,"profit":true}]
Total Non-Operating Income/Expense(1.58B)108.00M(1.51B)(1.61B)(1.42B)[{"date":"2019-12-31","value":-1462.96,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1401.85,"profit":false},{"date":"2022-12-31","value":-1488.89,"profit":false},{"date":"2023-12-31","value":-1311.11,"profit":false}]
Pre-Tax Income6.22B6.97B5.44B5.63B6.06B[{"date":"2019-12-31","value":89.28,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":78.1,"profit":true},{"date":"2022-12-31","value":80.77,"profit":true},{"date":"2023-12-31","value":87.03,"profit":true}]
Income Taxes953.00M580.00M346.00M707.00M756.00M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":60.86,"profit":true},{"date":"2021-12-31","value":36.31,"profit":true},{"date":"2022-12-31","value":74.19,"profit":true},{"date":"2023-12-31","value":79.33,"profit":true}]
Income After Taxes5.27B6.39B5.10B4.92B5.31B[{"date":"2019-12-31","value":82.47,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":79.77,"profit":true},{"date":"2022-12-31","value":77.04,"profit":true},{"date":"2023-12-31","value":83.09,"profit":true}]
Income From Continuous Operations5.27B6.39B5.10B4.92B6.54B[{"date":"2019-12-31","value":80.61,"profit":true},{"date":"2020-12-31","value":97.75,"profit":true},{"date":"2021-12-31","value":77.98,"profit":true},{"date":"2022-12-31","value":75.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations876.00M876.00M1.07B10.49B-[{"date":"2019-12-31","value":8.35,"profit":true},{"date":"2020-12-31","value":8.35,"profit":true},{"date":"2021-12-31","value":10.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income4.64B5.75B4.38B4.92B4.93B[{"date":"2019-12-31","value":80.8,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":76.27,"profit":true},{"date":"2022-12-31","value":85.6,"profit":true},{"date":"2023-12-31","value":85.72,"profit":true}]
EPS (Diluted)3.963.793.893.673.87[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":95.71,"profit":true},{"date":"2021-12-31","value":98.23,"profit":true},{"date":"2022-12-31","value":92.68,"profit":true},{"date":"2023-12-31","value":97.73,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

GSK
Cash Ratio 0.15
Current Ratio 0.81
Quick Ratio 0.53

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GSK
ROA (LTM) 7.24%
ROE (LTM) 21.85%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GSK
Debt Ratio Lower is generally better. Negative is bad. 0.77
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.24

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GSK
Trailing PE 23.25
Forward PE 8.24
P/S (TTM) 2.29
P/B 4.15
Price/FCF 55
EV/R 2.24
EV/Ebitda 10.45
PEG 0.81

FAQs

What is GlaxoSmithKline PLC ADR share price today?

GlaxoSmithKline PLC ADR (GSK) share price today is $35.06

Can Indians buy GlaxoSmithKline PLC ADR shares?

Yes, Indians can buy shares of GlaxoSmithKline PLC ADR (GSK) on Vested. To buy GlaxoSmithKline PLC ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GSK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of GlaxoSmithKline PLC ADR be purchased?

Yes, you can purchase fractional shares of GlaxoSmithKline PLC ADR (GSK) via the Vested app. You can start investing in GlaxoSmithKline PLC ADR (GSK) with a minimum investment of $1.

How to invest in GlaxoSmithKline PLC ADR shares from India?

You can invest in shares of GlaxoSmithKline PLC ADR (GSK) via Vested in three simple steps:

  • Click on Sign Up or Invest in GSK stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in GlaxoSmithKline PLC ADR shares
What is GlaxoSmithKline PLC ADR 52-week high and low stock price?

The 52-week high price of GlaxoSmithKline PLC ADR (GSK) is $44.85. The 52-week low price of GlaxoSmithKline PLC ADR (GSK) is $31.72.

What is GlaxoSmithKline PLC ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of GlaxoSmithKline PLC ADR (GSK) is 23.245

What is GlaxoSmithKline PLC ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of GlaxoSmithKline PLC ADR (GSK) is 4.15

What is GlaxoSmithKline PLC ADR dividend yield?

The dividend yield of GlaxoSmithKline PLC ADR (GSK) is 4.44%

What is the Market Cap of GlaxoSmithKline PLC ADR?

The market capitalization of GlaxoSmithKline PLC ADR (GSK) is $71.53B

What is GlaxoSmithKline PLC ADR’s stock symbol?

The stock symbol (or ticker) of GlaxoSmithKline PLC ADR is GSK

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top